Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY.

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...

On Thursday’s episode of Mad Money, host Jim Cramer turned his focus to large-cap stocks that surged by $10 or more in a single day.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

Even just a couple of hundreds of pounds invested monthly can create an enormous Stocks and Shares ISA. Royston Wild explains ...

FBCG, a large-cap growth ETF, excels in bullish markets but struggles in downturns. Learn why it's rated Hold amid current ...

Analysts are all over Eli Lilly, and most suggest a "Moderate Buy." Sixteen analysts recommend buying, while three say "hold.

The Global Bipolar Disorder Market report forecasts significant growth from 2025 to 2035, driven by rising prevalence, awareness, and pharmacotherapy ...

Detailed price information for Harvest Eli Lilly Enhanced High Income S (LLHE-T) from The Globe and Mail including charting and trades.